img

Global Marek's Disease Vaccine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Marek's Disease Vaccine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Marek's Disease Vaccine is used to prevent Marek's disease in chickens, which is the three major diseases that endanger the healthy development of the chicken industry.
Marek's Disease Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Marek's Disease Vaccine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Veterinary Pharmacy and Online Sale are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Marek's Disease Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Marek's Disease Vaccine key manufacturers include Merck, Ceva, Zoetis, Boehringer Ingelheim, Guangdong Wen's Dahuanong Biotechnology Co., Ltd., Merial, Ruipu Biopharmaceutical Co., Ltd., Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. and Beijing Huadu Shihua Biological Products Co., Ltd., etc. Merck, Ceva, Zoetis are top 3 players and held % sales share in total in 2022.
Marek's Disease Vaccine can be divided into Bivalent Vaccine and Monovalent Vaccine, etc. Bivalent Vaccine is the mainstream product in the market, accounting for % sales share globally in 2022.
Marek's Disease Vaccine is widely used in various fields, such as Veterinary Pharmacy, Online Sale and Others,, etc. Veterinary Pharmacy provides greatest supports to the Marek's Disease Vaccine industry development. In 2022, global % sales of Marek's Disease Vaccine went into Veterinary Pharmacy filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Marek's Disease Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck
Ceva
Zoetis
Boehringer Ingelheim
Guangdong Wen's Dahuanong Biotechnology Co., Ltd.
Merial
Ruipu Biopharmaceutical Co., Ltd.
Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
Beijing Huadu Shihua Biological Products Co., Ltd.
Guangxi Lichengdong Biological Co., Ltd.
Segment by Type
Bivalent Vaccine
Monovalent Vaccine

Segment by Application


Veterinary Pharmacy
Online Sale
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Marek's Disease Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Marek's Disease Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Marek's Disease Vaccine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Marek's Disease Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Marek's Disease Vaccine introduction, etc. Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Marek's Disease Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Marek's Disease Vaccine Market Overview
1.1 Marek's Disease Vaccine Product Overview
1.2 Marek's Disease Vaccine Market Segment by Type
1.2.1 Bivalent Vaccine
1.2.2 Monovalent Vaccine
1.3 Global Marek's Disease Vaccine Market Size by Type
1.3.1 Global Marek's Disease Vaccine Market Size Overview by Type (2024-2034)
1.3.2 Global Marek's Disease Vaccine Historic Market Size Review by Type (2024-2024)
1.3.3 Global Marek's Disease Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Marek's Disease Vaccine Sales Breakdown by Type (2024-2024)
1.4.2 Europe Marek's Disease Vaccine Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Marek's Disease Vaccine Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Marek's Disease Vaccine Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Marek's Disease Vaccine Sales Breakdown by Type (2024-2024)
2 Global Marek's Disease Vaccine Market Competition by Company
2.1 Global Top Players by Marek's Disease Vaccine Sales (2024-2024)
2.2 Global Top Players by Marek's Disease Vaccine Revenue (2024-2024)
2.3 Global Top Players by Marek's Disease Vaccine Price (2024-2024)
2.4 Global Top Manufacturers Marek's Disease Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Marek's Disease Vaccine Market Competitive Situation and Trends
2.5.1 Marek's Disease Vaccine Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Marek's Disease Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Marek's Disease Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Marek's Disease Vaccine Market
2.8 Key Manufacturers Marek's Disease Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Marek's Disease Vaccine Status and Outlook by Region
3.1 Global Marek's Disease Vaccine Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Marek's Disease Vaccine Historic Market Size by Region
3.2.1 Global Marek's Disease Vaccine Sales in Volume by Region (2024-2024)
3.2.2 Global Marek's Disease Vaccine Sales in Value by Region (2024-2024)
3.2.3 Global Marek's Disease Vaccine Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Marek's Disease Vaccine Forecasted Market Size by Region
3.3.1 Global Marek's Disease Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Marek's Disease Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Marek's Disease Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Marek's Disease Vaccine by Application
4.1 Marek's Disease Vaccine Market Segment by Application
4.1.1 Veterinary Pharmacy
4.1.2 Online Sale
4.1.3 Others
4.2 Global Marek's Disease Vaccine Market Size by Application
4.2.1 Global Marek's Disease Vaccine Market Size Overview by Application (2024-2034)
4.2.2 Global Marek's Disease Vaccine Historic Market Size Review by Application (2024-2024)
4.2.3 Global Marek's Disease Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Marek's Disease Vaccine Sales Breakdown by Application (2024-2024)
4.3.2 Europe Marek's Disease Vaccine Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Marek's Disease Vaccine Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Marek's Disease Vaccine Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Marek's Disease Vaccine Sales Breakdown by Application (2024-2024)
5 North America Marek's Disease Vaccine by Country
5.1 North America Marek's Disease Vaccine Historic Market Size by Country
5.1.1 North America Marek's Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Marek's Disease Vaccine Sales in Volume by Country (2024-2024)
5.1.3 North America Marek's Disease Vaccine Sales in Value by Country (2024-2024)
5.2 North America Marek's Disease Vaccine Forecasted Market Size by Country
5.2.1 North America Marek's Disease Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Marek's Disease Vaccine Sales in Value by Country (2024-2034)
6 Europe Marek's Disease Vaccine by Country
6.1 Europe Marek's Disease Vaccine Historic Market Size by Country
6.1.1 Europe Marek's Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Marek's Disease Vaccine Sales in Volume by Country (2024-2024)
6.1.3 Europe Marek's Disease Vaccine Sales in Value by Country (2024-2024)
6.2 Europe Marek's Disease Vaccine Forecasted Market Size by Country
6.2.1 Europe Marek's Disease Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Marek's Disease Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Marek's Disease Vaccine by Region
7.1 Asia-Pacific Marek's Disease Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Marek's Disease Vaccine Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Marek's Disease Vaccine Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Marek's Disease Vaccine Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Marek's Disease Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Marek's Disease Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Marek's Disease Vaccine Sales in Value by Region (2024-2034)
8 Latin America Marek's Disease Vaccine by Country
8.1 Latin America Marek's Disease Vaccine Historic Market Size by Country
8.1.1 Latin America Marek's Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Marek's Disease Vaccine Sales in Volume by Country (2024-2024)
8.1.3 Latin America Marek's Disease Vaccine Sales in Value by Country (2024-2024)
8.2 Latin America Marek's Disease Vaccine Forecasted Market Size by Country
8.2.1 Latin America Marek's Disease Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Marek's Disease Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Marek's Disease Vaccine by Country
9.1 Middle East and Africa Marek's Disease Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Marek's Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Marek's Disease Vaccine Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Marek's Disease Vaccine Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Marek's Disease Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Marek's Disease Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Marek's Disease Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Marek's Disease Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Merck Marek's Disease Vaccine Products Offered
10.1.5 Merck Recent Development
10.2 Ceva
10.2.1 Ceva Company Information
10.2.2 Ceva Introduction and Business Overview
10.2.3 Ceva Marek's Disease Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Ceva Marek's Disease Vaccine Products Offered
10.2.5 Ceva Recent Development
10.3 Zoetis
10.3.1 Zoetis Company Information
10.3.2 Zoetis Introduction and Business Overview
10.3.3 Zoetis Marek's Disease Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Zoetis Marek's Disease Vaccine Products Offered
10.3.5 Zoetis Recent Development
10.4 Boehringer Ingelheim
10.4.1 Boehringer Ingelheim Company Information
10.4.2 Boehringer Ingelheim Introduction and Business Overview
10.4.3 Boehringer Ingelheim Marek's Disease Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Boehringer Ingelheim Marek's Disease Vaccine Products Offered
10.4.5 Boehringer Ingelheim Recent Development
10.5 Guangdong Wen's Dahuanong Biotechnology Co., Ltd.
10.5.1 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Company Information
10.5.2 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Introduction and Business Overview
10.5.3 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Products Offered
10.5.5 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Recent Development
10.6 Merial
10.6.1 Merial Company Information
10.6.2 Merial Introduction and Business Overview
10.6.3 Merial Marek's Disease Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Merial Marek's Disease Vaccine Products Offered
10.6.5 Merial Recent Development
10.7 Ruipu Biopharmaceutical Co., Ltd.
10.7.1 Ruipu Biopharmaceutical Co., Ltd. Company Information
10.7.2 Ruipu Biopharmaceutical Co., Ltd. Introduction and Business Overview
10.7.3 Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Products Offered
10.7.5 Ruipu Biopharmaceutical Co., Ltd. Recent Development
10.8 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
10.8.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information
10.8.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Introduction and Business Overview
10.8.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Products Offered
10.8.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Development
10.9 Beijing Huadu Shihua Biological Products Co., Ltd.
10.9.1 Beijing Huadu Shihua Biological Products Co., Ltd. Company Information
10.9.2 Beijing Huadu Shihua Biological Products Co., Ltd. Introduction and Business Overview
10.9.3 Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Products Offered
10.9.5 Beijing Huadu Shihua Biological Products Co., Ltd. Recent Development
10.10 Guangxi Lichengdong Biological Co., Ltd.
10.10.1 Guangxi Lichengdong Biological Co., Ltd. Company Information
10.10.2 Guangxi Lichengdong Biological Co., Ltd. Introduction and Business Overview
10.10.3 Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Products Offered
10.10.5 Guangxi Lichengdong Biological Co., Ltd. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Marek's Disease Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Marek's Disease Vaccine Industrial Chain Analysis
11.4 Marek's Disease Vaccine Market Dynamics
11.4.1 Marek's Disease Vaccine Industry Trends
11.4.2 Marek's Disease Vaccine Market Drivers
11.4.3 Marek's Disease Vaccine Market Challenges
11.4.4 Marek's Disease Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Marek's Disease Vaccine Distributors
12.3 Marek's Disease Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Bivalent Vaccine
Table 2. Major Company of Monovalent Vaccine
Table 3. Global Marek's Disease Vaccine Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Marek's Disease Vaccine Sales by Type (2024-2024) & (K Units)
Table 5. Global Marek's Disease Vaccine Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Marek's Disease Vaccine Sales by Type (2024-2024) & (US& Million)
Table 7. Global Marek's Disease Vaccine Market Share in Value by Type (2024-2024)
Table 8. Global Marek's Disease Vaccine Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Marek's Disease Vaccine Sales by Type (2024-2034) & (K Units)
Table 10. Global Marek's Disease Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Marek's Disease Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Marek's Disease Vaccine Sales Market Share in Value by Type (2024-2034)
Table 13. Global Marek's Disease Vaccine Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Marek's Disease Vaccine Sales by Type (2024-2024) & (K Units)
Table 15. North America Marek's Disease Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Marek's Disease Vaccine Sales (K Units) by Type (2024-2024)
Table 17. Europe Marek's Disease Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Marek's Disease Vaccine Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Marek's Disease Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Marek's Disease Vaccine Sales (K Units) by Type (2024-2024)
Table 21. Latin America Marek's Disease Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Marek's Disease Vaccine Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Marek's Disease Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Marek's Disease Vaccine Sales by Company (2024-2024) & (K Units)
Table 25. Global Marek's Disease Vaccine Sales Share by Company (2024-2024)
Table 26. Global Marek's Disease Vaccine Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Marek's Disease Vaccine Revenue Share by Company (2024-2024)
Table 28. Global Market Marek's Disease Vaccine Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Marek's Disease Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Marek's Disease Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Marek's Disease Vaccine as of 2022)
Table 32. Date of Key Manufacturers Enter into Marek's Disease Vaccine Market
Table 33. Key Manufacturers Marek's Disease Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Marek's Disease Vaccine Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Marek's Disease Vaccine Sales by Region (2024-2024) & (K Units)
Table 37. Global Marek's Disease Vaccine Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Marek's Disease Vaccine Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Marek's Disease Vaccine Sales Market Share in Value by Region (2024-2024)
Table 40. Global Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Marek's Disease Vaccine Sales by Region (2024-2034) & (K Units)
Table 42. Global Marek's Disease Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Marek's Disease Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Marek's Disease Vaccine Sales Market Share in Value by Region (2024-2034)
Table 45. Global Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Marek's Disease Vaccine Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Marek's Disease Vaccine Sales by Application (2024-2024) & (K Units)
Table 48. Global Marek's Disease Vaccine Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Marek's Disease Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Marek's Disease Vaccine Sales Market Share in Value by Application (2024-2024)
Table 51. Global Marek's Disease Vaccine Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Marek's Disease Vaccine Sales by Application (2024-2034) & (K Units)
Table 53. Global Marek's Disease Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Marek's Disease Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Marek's Disease Vaccine Sales Market Share in Value by Application (2024-2034)
Table 56. Global Marek's Disease Vaccine Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Marek's Disease Vaccine Sales by Application (2024-2024) (K Units)
Table 58. North America Marek's Disease Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Marek's Disease Vaccine Sales by Application (2024-2024) (K Units)
Table 60. Europe Marek's Disease Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Marek's Disease Vaccine Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Marek's Disease Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Marek's Disease Vaccine Sales by Application (2024-2024) (K Units)
Table 64. Latin America Marek's Disease Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Marek's Disease Vaccine Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Marek's Disease Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Marek's Disease Vaccine Sales by Country (2024-2024) & (K Units)
Table 68. North America Marek's Disease Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Marek's Disease Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Marek's Disease Vaccine Sales Market Share in Value by Country (2024-2024)
Table 71. North America Marek's Disease Vaccine Sales by Country (2024-2034) & (K Units)
Table 72. North America Marek's Disease Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Marek's Disease Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Marek's Disease Vaccine Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Marek's Disease Vaccine Sales by Country (2024-2024) & (K Units)
Table 76. Europe Marek's Disease Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Marek's Disease Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Marek's Disease Vaccine Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Marek's Disease Vaccine Sales by Country (2024-2034) & (K Units)
Table 80. Europe Marek's Disease Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Marek's Disease Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Marek's Disease Vaccine Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Marek's Disease Vaccine Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Marek's Disease Vaccine Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Marek's Disease Vaccine Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Marek's Disease Vaccine Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Marek's Disease Vaccine Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Marek's Disease Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Marek's Disease Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Marek's Disease Vaccine Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Marek's Disease Vaccine Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Marek's Disease Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Marek's Disease Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Marek's Disease Vaccine Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Marek's Disease Vaccine Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Marek's Disease Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Marek's Disease Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Marek's Disease Vaccine Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Marek's Disease Vaccine Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Marek's Disease Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Marek's Disease Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Marek's Disease Vaccine Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Marek's Disease Vaccine Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Marek's Disease Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Marek's Disease Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Marek's Disease Vaccine Sales Market Share in Value by Country (2024-2034)
Table 107. Merck Company Information
Table 108. Merck Introduction and Business Overview
Table 109. Merck Marek's Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. Merck Marek's Disease Vaccine Product
Table 111. Merck Recent Development
Table 112. Ceva Company Information
Table 113. Ceva Introduction and Business Overview
Table 114. Ceva Marek's Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Ceva Marek's Disease Vaccine Product
Table 116. Ceva Recent Development
Table 117. Zoetis Company Information
Table 118. Zoetis Introduction and Business Overview
Table 119. Zoetis Marek's Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Zoetis Marek's Disease Vaccine Product
Table 121. Zoetis Recent Development
Table 122. Boehringer Ingelheim Company Information
Table 123. Boehringer Ingelheim Introduction and Business Overview
Table 124. Boehringer Ingelheim Marek's Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. Boehringer Ingelheim Marek's Disease Vaccine Product
Table 126. Boehringer Ingelheim Recent Development
Table 127. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Company Information
Table 128. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Introduction and Business Overview
Table 129. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Product
Table 131. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Recent Development
Table 132. Merial Company Information
Table 133. Merial Introduction and Business Overview
Table 134. Merial Marek's Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Merial Marek's Disease Vaccine Product
Table 136. Merial Recent Development
Table 137. Ruipu Biopharmaceutical Co., Ltd. Company Information
Table 138. Ruipu Biopharmaceutical Co., Ltd. Introduction and Business Overview
Table 139. Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Product
Table 141. Ruipu Biopharmaceutical Co., Ltd. Recent Development
Table 142. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information
Table 143. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Introduction and Business Overview
Table 144. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Product
Table 146. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Development
Table 147. Beijing Huadu Shihua Biological Products Co., Ltd. Company Information
Table 148. Beijing Huadu Shihua Biological Products Co., Ltd. Introduction and Business Overview
Table 149. Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Product
Table 151. Beijing Huadu Shihua Biological Products Co., Ltd. Recent Development
Table 152. Guangxi Lichengdong Biological Co., Ltd. Company Information
Table 153. Guangxi Lichengdong Biological Co., Ltd. Introduction and Business Overview
Table 154. Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Product
Table 156. Guangxi Lichengdong Biological Co., Ltd. Recent Development
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Marek's Disease Vaccine Market Trends
Table 160. Marek's Disease Vaccine Market Drivers
Table 161. Marek's Disease Vaccine Market Challenges
Table 162. Marek's Disease Vaccine Market Restraints
Table 163. Marek's Disease Vaccine Distributors List
Table 164. Marek's Disease Vaccine Downstream Customers
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Marek's Disease Vaccine Product Picture
Figure 2. Global Marek's Disease Vaccine Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Marek's Disease Vaccine Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Marek's Disease Vaccine Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Bivalent Vaccine
Figure 6. Global Bivalent Vaccine Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Monovalent Vaccine
Figure 8. Global Monovalent Vaccine Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Marek's Disease Vaccine Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Marek's Disease Vaccine Sales Market Share by Type in 2022 & 2034
Figure 11. North America Marek's Disease Vaccine Sales Market Share in Volume by Type in 2022
Figure 12. North America Marek's Disease Vaccine Sales Market Share in Value by Type in 2022
Figure 13. Europe Marek's Disease Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Marek's Disease Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Marek's Disease Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Marek's Disease Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Marek's Disease Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Marek's Disease Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Marek's Disease Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Marek's Disease Vaccine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Marek's Disease Vaccine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Marek's Disease Vaccine Revenue in 2022
Figure 23. Marek's Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Veterinary Pharmacy
Figure 25. Global Veterinary Pharmacy Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Online Sale
Figure 27. Global Online Sale Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Others
Figure 29. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Global Marek's Disease Vaccine Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Marek's Disease Vaccine Sales Market Share by Application in 2022 & 2034
Figure 32. North America Marek's Disease Vaccine Sales Market Share in Volume by Application in 2022
Figure 33. North America Marek's Disease Vaccine Sales Market Share in Value by Application in 2022
Figure 34. Europe Marek's Disease Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. Europe Marek's Disease Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Marek's Disease Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Marek's Disease Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Latin America Marek's Disease Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Marek's Disease Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Marek's Disease Vaccine Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Marek's Disease Vaccine Manufacturing Cost Structure
Figure 43. Marek's Disease Vaccine Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed